Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Centrosome loss results in an unstable genome and malignant prostate tumors

Oncogene volume 39, pages 399–413 (2020)Cite this article

Subjects

Abstract

Localized, nonindolent prostate cancer (PCa) is characterized by large-scale genomic rearrangements, aneuploidy, chromothripsis, and other forms of chromosomal instability (CIN), yet how this occurs remains unclear. A well-established mechanism of CIN is the overproduction of centrosomes, which promotes tumorigenesis in various mouse models. Therefore, we developed a single-cell assay for quantifying centrosomes in human prostate tissue. Surprisingly, centrosome loss—which has not been described in human cancer—was associated with PCa progression. By chemically or genetically inducing centrosome loss in nontumorigenic prostate epithelial cells, mitotic errors ensued, producing aneuploid, and multinucleated cells. Strikingly, transient or chronic centrosome loss transformed prostate epithelial cells, which produced highly proliferative and poorly differentiated malignant tumors in mice. Our findings suggest that centrosome loss could create a cellular crisis with oncogenic potential in prostate epithelial cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, et al. Punctuated evolution of prostate cancer genomes. Cell. 2013;153:666–77.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Boutros PC, Fraser M, Harding NJ, de Borja R, Trudel D, Lalonde E, et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat Genet. 2015;47:736–45.

    CAS  PubMed  Google Scholar 

  3. Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2008;50:645–51.

    Google Scholar 

  4. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44:685–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017;541:359–64.

    CAS  PubMed  Google Scholar 

  6. Robinson DR, Wu YM, Lonigro RJ, Vats P, Cobain E, Everett J, et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548:297–330.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Wu YM, Cieslik M, Lonigro RJ, Vats P, Reimers MA, Cao X. et al. Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer. Cell. 2018;173:1770–82.

    CAS  PubMed  Google Scholar 

  8. Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011–25.

    Google Scholar 

  9. Petein M, Michel P, van Velthoven R, Pasteels JL, Brawer MK, Davis JR, et al. Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol. 1991;96:628–34.

    CAS  PubMed  Google Scholar 

  10. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–8.

    CAS  PubMed  Google Scholar 

  11. Espiritu SMG, Liu LY, Rubanova Y, Bhandari V, Holgersen EM, Szyca LM. et al. The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell. 2018;173:1003–13.

    CAS  PubMed  Google Scholar 

  12. Conduit PT, Wainman A, Raff JW. Centrosome function and assembly in animal cells. Nat Rev Mol Cell Biol. 2015;16:611–24.

    CAS  PubMed  Google Scholar 

  13. Bettencourt-Dias M, Glover DM. Centrosome biogenesis and function: centrosomics brings new understanding. Nat Rev Mol Cell Biol. 2007;8:451–63.

    CAS  PubMed  Google Scholar 

  14. Lawo S, Hasegan M, Gupta GD, Pelletier L. Subdiffraction imaging of centrosomes reveals higher-order organizational features of pericentriolar material. Nat Cell Biol. 2012;14:1148–58.

    CAS  PubMed  Google Scholar 

  15. Nigg EA, Holland AJ. Once and only once: mechanisms of centriole duplication and their deregulation in disease. Nat Rev Mol Cell Biol. 2018;19:297–312.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Godinho SA, Pellman D. Causes and consequences of centrosome abnormalities in cancer. Philos Trans R Soc Lond B Biol Sci. 2014;369 pii: 20130467. https://doi.org/10.1098/rstb.2013.0467.

    Google Scholar 

  17. Chan JY. A clinical overview of centrosome amplification in human cancers. Int J Biol Sci. 2011;7:1122–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460:278–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Silkworth WT, Nardi IK, Scholl LM, Cimini D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS ONE. 2009;4:e6564.

    PubMed  PubMed Central  Google Scholar 

  20. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature. 2012;482:53–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Coelho PA, Bury L, Shahbazi MN, Liakath-Ali K, Tate PH, Wormald S, et al. Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse. Open Biol. 2015;5:150209.

    PubMed  PubMed Central  Google Scholar 

  22. Levine MS, Bakker B, Boeckx B, Moyett J, Lu J, Vitre B, et al. Centrosome amplification Is sufficient to promote spontaneous tumorigenesis in mammals. Dev Cell. 2017;40:313–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Sercin O, Larsimont JC, Karambelas AE, Marthiens V, Moers V, Boeckx B, et al. Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis. Nat Cell Biol. 2016;18:100–10.

    CAS  PubMed  Google Scholar 

  24. Vitre B, Holland AJ, Kulukian A, Shoshani O, Hirai M, Wang Y, et al. Chronic centrosome amplification without tumorigenesis. Proc Natl Acad Sci USA. 2015;112:E6321–30.

    CAS  PubMed  Google Scholar 

  25. Meunier S, Vernos I. Acentrosomal microtubule assembly in mitosis: the where, when, and how. Trends Cell Biol. 2016;26:80–7.

    CAS  PubMed  Google Scholar 

  26. Bazzi H, Anderson KV. Acentriolar mitosis activates a p53-dependent apoptosis pathway in the mouse embryo. Proc Natl Acad Sci USA. 2014;111:E1491–500.

    CAS  PubMed  Google Scholar 

  27. Lambrus BG, Uetake Y, Clutario KM, Daggubati V, Snyder M, Sluder G, et al. p53 protects against genome instability following centriole duplication failure. J Cell Biol. 2015;210:63–77.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Wong YL, Anzola JV, Davis RL, Yoon M, Motamedi A, Kroll A, et al. Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4. Science. 2015;348:1155–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Khodjakov A, Rieder CL. Centrosomes enhance the fidelity of cytokinesis in vertebrates and are required for cell cycle progression. J Cell Biol. 2001;153:237–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Sir JH, Putz M, Daly O, Morrison CG, Dunning M, Kilmartin JV, et al. Loss of centrioles causes chromosomal instability in vertebrate somatic cells. J Cell Biol. 2013;203:747–56.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Wang, M, Knudsen, BS, Nagle RB, Rogers GC, Cress AE. A method to quantify centrosomes at single-cell level in human normal and cancer tissue. Mol Biol Cell. 2019. https://doi.org/10.1091/mcb.E18-10-0651.

  32. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol. 2001;32:690–7.

    CAS  PubMed  Google Scholar 

  33. Denu RA, Zasadil LM, Kanugh C, Laffin J, Weaver BA, Burkard ME. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer. BMC Cancer. 2016;16:47.

    PubMed  PubMed Central  Google Scholar 

  34. Chatterjee SJ, McCaffrey L. Emerging role of cell polarity proteins in breast cancer progression and metastasis. Breast Cancer. 2014;6:15–27.

    PubMed  Google Scholar 

  35. Ouyang X, Wang X, Xu K, Jin DY, Cheung AL, Tsao SW, et al. Effect of p53 on centrosome amplification in prostate cancer cells. Biochim Biophys Acta. 2001;1541:212–20.

    CAS  PubMed  Google Scholar 

  36. Cosenza MR, Cazzola A, Rossberg A, Schieber NL, Konotop G, Bausch E. et al. Asymmetric centriole numbers at spindle poles cause chromosome missegregation in cancer. Cell Rep. 2017;20:1906–20.

    CAS  PubMed  Google Scholar 

  37. Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, et al. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res. 2004;64:8867–75.

    CAS  PubMed  Google Scholar 

  38. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis. 1997;18:1215–23.

    CAS  PubMed  Google Scholar 

  39. Cangemi R, Mensah A, Albertini V, Jain A, Mello-Grand M, Chiorino G, et al. Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer. Oncogene. 2008;27:2877–85.

    CAS  PubMed  Google Scholar 

  40. Rickman DS, Soong TD, Moss B, Mosquera JM, Dlabal J, Terry S, et al. Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci USA. 2012;109:9083–8.

    CAS  PubMed  Google Scholar 

  41. Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature. 2005;437:1038–42.

    CAS  PubMed  Google Scholar 

  42. Bettencourt-Dias M, Rodrigues-Martins A, Carpenter L, Riparbelli M, Lehmann L, Gatt MK, et al. SAK/PLK4 is required for centriole duplication and flagella development. Curr Biol. 2005;15:2199–207.

    CAS  PubMed  Google Scholar 

  43. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol. 2005;7:1140–6.

    CAS  PubMed  Google Scholar 

  44. Gregan J, Polakova S, Zhang L, Tolic-Norrelykke IM, Cimini D. Merotelic kinetochore attachment: causes and effects. Trends Cell Biol. 2011;21:374–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE. A basal cell defect promotes budding of prostatic intraepithelial neoplasia. J Cell Sci. 2017;130:104–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Malhas AN, Vaux DJ. Nuclear envelope invaginations and cancer. Adv Exp Med Biol. 2014;773:523–35.

    CAS  PubMed  Google Scholar 

  47. Xue JZ, Woo EM, Postow BT, Chait H, Funabiki H. Chromatin-bound Xenopus Dppa2 shapes the nucleus by locally inhibiting microtubule assembly. Dev Cell. 2013;27:47–59.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Beheshti B, Park PC, Sweet JM, Trachtenberg J, Jewett MA, Squire JA. Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis. Neoplasia. 2001;3:62–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene. 2008;27:5348–53.

    CAS  PubMed  Google Scholar 

  50. Zeng W, Sun H, Meng F, Liu Z, Xiong J, Zhou S, et al. Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer. Int J Clin Exp Pathol. 2015;8:1878–88.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Lipponen P, Aaltomaa S, Tammi R, Tammi M, Agren U, Kosma VM. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer. 2001;37:849–56.

    CAS  PubMed  Google Scholar 

  52. Werner S, Pimenta-Marques A, Bettencourt-Dias M. Maintaining centrosomes and cilia. J Cell Sci. 2017;130:3789–3800.

    CAS  PubMed  Google Scholar 

  53. Pimenta-Marques A, Bento I, Lopes CA, Duarte P, Jana SC, Bettencourt-Dias M. A mechanism for the elimination of the female gamete centrosome in Drosophila melanogaster. Science. 2016;353:aaf4866.

    CAS  PubMed  Google Scholar 

  54. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 2001;61:2212–9.

    CAS  PubMed  Google Scholar 

  55. Godinho SA, Picone R, Burute M, Dagher R, Su Y, Leung CT, et al. Oncogene-like induction of cellular invasion from centrosome amplification. Nature. 2014;510:167–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Kushner EJ, Ferro LS, Liu JY, Durrant JR, Rogers SL, Dudley AC, et al. Excess centrosomes disrupt endothelial cell migration via centrosome scattering. J Cell Biol. 2014;206:257–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Edick MJ, Tesfay L, Lamb LE, Knudsen BS, Miranti CK. Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol Biol Cell. 2007;18:2481–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Gmyrek GA, Walburg M, Webb CP, Yu HM, You X, Vaughan ED, et al. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol. 2001;159:579–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. van Bokhoven A, Varella-Garcia M, Korch C, Hessels D, Miller GJ. Widely used prostate carcinoma cell lines share common origins. Prostate. 2001;47:36–51.

    PubMed  Google Scholar 

Download references

Acknowledgements

We thank K. Oegema for providing centrinone and CRISPR constructs, D. Pellman for histone-H2B construct, V. Bautch for centrin1 construct, W. Hahn for PrEC cells, C. Miranti for iPEC37 cells, and N. Ellis and J. DeLuca for technical advice. Tissue samples were obtained from the PCa Biorepository Network (PCBN) (DoD PCa Research Program Award No W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, and W81XWH-15-2-0062). This work was supported by NIH grants NCI P30 CA23074, R01GM110166, and R01GM126035 to GCR, R01CA159406 to AEC and Tim and Diane Bowden Cancer Biology Research Fellowship to MW.

Author information

Authors and Affiliations

  1. Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA

    Mengdie Wang, Anne E. Cress & Gregory C. Rogers

  2. Department of Pathology, University of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA

    Raymond B. Nagle

  3. Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA, 90048, USA

    Beatrice S. Knudsen

Authors
  1. Mengdie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raymond B. Nagle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beatrice S. Knudsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne E. Cress
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gregory C. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Anne E. Cress or Gregory C. Rogers.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, M., Nagle, R.B., Knudsen, B.S. et al. Centrosome loss results in an unstable genome and malignant prostate tumors. Oncogene 39, 399–413 (2020). https://doi.org/10.1038/s41388-019-0995-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-019-0995-z

This article is cited by

Search

Advanced search

Quick links